ERDERA Joint Transnational Call 2025 "Pre-clinical therapy studies for rare diseases using small molecules
and biologicals – development and validation" · European Partnership on Rare Diseases · Opportunity · GRANTIBASE · GRANTIBASE
ERDERA Joint Transnational Call 2025 "Pre-clinical therapy studies for rare diseases using small molecules
and biologicals – development and validation" · European Partnership on Rare Diseases
Horizon EuropeHorizon Europe€32.6m
There are at least 7000 distinct rare diseases, the great majority being of genetic origin. Although individually rare, taken together rare diseases affect at least 26-30 million people in Europe. Moreover, they represent a major issue in health care: many of these diseases have an early or very ea…